Insider Stock Trading History of Schwab Gisela


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schwab Gisela since year 2005. The trader's CIK number is 1213140. At the time of this reporting, Schwab Gisela is the Pres Prod Dev & Med Aff & CMO of Exelixis, Inc. . (stock ticker symbol EXEL). See this page for all insider trading activities at Exelixis, Inc. .

Note that in the past Schwab Gisela also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Schwab Gisela since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-09-04 EXEL Exelixis, Inc. Sale 22,500 18.53 416,925
2018-09-04 EXEL Exelixis, Inc. Option Ex 22,500 5.50 123,750
2018-08-17 EXEL Exelixis, Inc. Option Ex 50,000 5.51 275,500
2018-08-01 EXEL Exelixis, Inc. Option Ex 22,500 5.50 123,750
2018-08-01 EXEL Exelixis, Inc. Sale 22,500 20.56 462,600
2018-07-02 EXEL Exelixis, Inc. Sale 22,500 21.20 477,000
2018-07-02 EXEL Exelixis, Inc. Option Ex 22,500 5.50 123,750
2018-06-01 EXEL Exelixis, Inc. Sale 22,500 20.80 468,000
2018-06-01 EXEL Exelixis, Inc. Option Ex 22,500 5.50 123,750
2018-05-03 EXEL Exelixis, Inc. Sale 22,500 22.91 515,587
2018-05-03 EXEL Exelixis, Inc. Option Ex 22,500 5.50 123,750
2018-04-06 EXEL Exelixis, Inc. Option Ex 14,591 7.18 104,763
2018-03-01 EXEL Exelixis, Inc. Option Ex 7,293 4.42 32,235
2017-09-28 EXEL Exelixis, Inc. Sale 33,334 23.74 791,349
2017-09-27 EXEL Exelixis, Inc. Sale 33,333 23.94 797,992
2017-09-28 EXEL Exelixis, Inc. Option Ex 33,334 9.91 330,339
2017-09-26 EXEL Exelixis, Inc. Sale 33,333 23.68 789,325
2017-09-27 EXEL Exelixis, Inc. Option Ex 33,333 9.91 330,330
2017-09-26 EXEL Exelixis, Inc. Option Ex 33,333 9.91 330,330
2017-05-15 EXEL Exelixis, Inc. Option Ex 12,501 5.04 63,005
2017-05-01 EXEL Exelixis, Inc. Sale 89,910 23.16 2,081,866
2017-05-01 EXEL Exelixis, Inc. Option Ex 89,910 9.91 891,008
2017-04-17 EXEL Exelixis, Inc. Option Ex 10,090 9.91 99,991
2017-03-15 EXEL Exelixis, Inc. Option Ex 50,007 5.80 290,040
2017-03-15 EXEL Exelixis, Inc. Sale 50,007 22.53 1,126,657
2016-12-01 EXEL Exelixis, Inc. Sale 22,000 16.73 368,060
2016-12-01 EXEL Exelixis, Inc. Option Ex 22,000 8.99 197,780
2016-11-09 EXEL Exelixis, Inc. Option Ex 22,000 8.99 197,780
2016-11-09 EXEL Exelixis, Inc. Sale 22,000 15.00 330,000
2016-08-31 EXEL Exelixis, Inc. Option Ex 132,662 9.73 1,290,801
2016-08-31 EXEL Exelixis, Inc. Sale 131,155 10.98 1,440,081
2016-08-04 EXEL Exelixis, Inc. Option Ex 42,338 9.73 411,948
2016-08-04 EXEL Exelixis, Inc. Sale 42,338 11.00 465,718
2015-11-16 EXEL Exelixis, Inc. Option Ex 3,125 .00 0
2014-11-15 EXEL Exelixis, Inc. Option Ex 3,125 .00 0
2014-02-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2013-11-15 EXEL Exelixis, Inc. Option Ex 5,312 .00 0
2013-08-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2013-05-15 EXEL Exelixis, Inc. Option Ex 2,187 .00 0
2013-02-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2012-12-10 EXEL Exelixis, Inc. Buy 25,000 4.39 109,749
2012-11-15 EXEL Exelixis, Inc. Option Ex 5,312 .00 0
2012-08-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2012-05-15 EXEL Exelixis, Inc. Option Ex 2,187 .00 0
2012-02-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2011-11-15 EXEL Exelixis, Inc. Option Ex 2,187 .00 0
2011-08-15 EXEL Exelixis, Inc. Option Ex 2,188 .00 0
2011-05-15 EXEL Exelixis, Inc. Option Ex 2,187 .00 0
2011-02-15 EXEL Exelixis, Inc. Option Ex 8,750 .00 0
2010-12-09 EXEL Exelixis, Inc. Sale 4,112 6.50 26,728
2009-06-03 EXEL Exelixis, Inc. Sale 8,197 5.00 41,025
2006-03-30 ABGX Abgenix Inc Option Ex 200,000 9.75 1,950,000
2006-03-24 ABGX Abgenix Inc Option Ex 51,812 9.75 505,167

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwab Gisela (Pres Prod Dev & Med Aff & CMO of Exelixis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.